跳至主要内容
临床试验/JPRN-jRCTs051180180
JPRN-jRCTs051180180已完成4 期

Prospective randomized trial to compare two treatment regimens of rituximab for adult refractory nephrotic syndrome - OPTIMALNS

Hayashi Terumasa0 个研究点目标入组 64 人开始时间: 2019年3月26日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients who have developed nephrotic syndrome at age less than 18 years old and have been dependent to steroid alone or a combination with calcineurin inhibitors.
  • 2) Patients who have developed nephrotic syndrome at 18 years old or older and have been dependent or resistant to steroid alone or a combination with calcineurin inhibitors and have been complicated with adverse effects of these drugs (e.g., diabetes, morbid fracture).
  • 3) Patients diagnosed by renal biopsy as having minimal change disease or focal segmental glomerulosclerosis.
  • 4) Patients who are at least 20 years old when they give informed consent.

排除标准

  • 1) Patients diagnosed by renal biopsy as having any pathology other than minimal change disease or focal segmental glomerulosclerosis.
  • 2) Patients with malignant disease or hematological disease.
  • 3) Patients who are or may be pregnant, breast-feeding or hope to be pregnant during the study period.

研究者

发起方
Hayashi Terumasa

相似试验